Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Japanese”

2,006 trials

Showing 20 of 2,006 results

Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Early research (Phase 1)Looking for participantsNCT07174063
What this trial is testing

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 15
Early research (Phase 1)Study completedNCT02675478
What this trial is testing

Phase 1 Study of Quizartinib

Who this might be right for
Relapsed AMLRefractory AML
Daiichi Sankyo Co., Ltd. 17
Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Early research (Phase 1)Ended earlyNCT02862535
What this trial is testing

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Gilead Sciences 36
Early research (Phase 1)Study completedNCT02673567
What this trial is testing

To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

Who this might be right for
Pharmacokinetics
Teva Branded Pharmaceutical Products R&D, Inc. 64
Early research (Phase 1)Study completedNCT01492647
What this trial is testing

JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

Who this might be right for
Acne Vulgaris
Janssen Pharmaceutical K.K. 18
Early research (Phase 1)Study completedNCT01919398
What this trial is testing

LY2940680 in Japanese Participants With Advanced Cancers

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 19
Post-approval studies (Phase 4)Study completedNCT01607398
What this trial is testing

ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 56
Early research (Phase 1)Study completedNCT02379793
What this trial is testing

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

Who this might be right for
Skin and Connective Tissue Diseases
LEO Pharma 33
Early research (Phase 1)Study completedNCT02447393
What this trial is testing

Phase 1 Study of Levocetirizine

Who this might be right for
Dermatitis
GlaxoSmithKline 20
Not applicableStudy completedNCT06934031
What this trial is testing

Interpretation Performance in Chinese and Japanese Medical Consultation Scenarios

Who this might be right for
OutpatientsCardiologyPulmonology
Fu Jen Catholic University 42
Early research (Phase 1)Study completedNCT04241549
What this trial is testing

Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment

Who this might be right for
Leukemia, Myeloid, Acute
OncoVerity, Inc. 6
Not applicableStudy completedNCT05791526
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

Who this might be right for
Ulcerative Colitis
AbbVie 308
Early research (Phase 1)Study completedNCT04094506
What this trial is testing

Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Astellas Pharma Inc 9
Post-approval studies (Phase 4)UnknownNCT00242047
What this trial is testing

Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.

Who this might be right for
Tuberculosis
University of Cape Town 12,000
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Not applicableLooking for participantsNCT04368663
What this trial is testing

The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

Who this might be right for
Pneumatosis Cystoides Intestinalis
Showa Inan General Hospital 100
Not applicableStudy completedNCT02238236
What this trial is testing

Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

Who this might be right for
Rhinitis, Allergic, Perennial
Boehringer Ingelheim 3,793
Not applicableStudy completedNCT03193034
What this trial is testing

DSJ-2016-07 ATTUNE® Cementless CR RP Japan

Who this might be right for
Osteoarthritis
DePuy Orthopaedics 81
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation